HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Siew-Lee Wong Selected Research

Lymphadenopathy

6/2022Safety and efficacy of eliglustat combined to enzyme replacement therapy for lymphadenopathy in patients with Gaucher disease type 3.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Siew-Lee Wong Research Topics

Disease

2Gaucher Disease (Gaucher's Disease)
06/2022 - 09/2014
1Lymphadenopathy
06/2022
1Congenital Generalized Lipodystrophy (Berardinelli-Seip Congenital Lipodystrophy)
10/2021
1Glycogen Storage Disease Type II (Pompe's Disease)
06/2020
1Diabetes Mellitus
01/2019
1Congenital Adrenal Hyperplasia (Hyperplasia, Congenital Adrenal)
02/2006
1Hypertension (High Blood Pressure)
02/2006
1Hypokalemia
02/2006
1Disorders of Sex Development (Intersexuality)
02/2006
1Sexual Infantilism
02/2006

Drug/Important Bio-Agent (IBA)

1eliglustatIBA
06/2022
1RNA (Ribonucleic Acid)IBA
10/2021
1human GAA protein (Myozyme)FDA Link
06/2020
1Hypoglycemic Agents (Hypoglycemics)IBA
01/2019
1Insulin (Novolin)FDA Link
01/2019
1GlucosidasesIBA
09/2014
1AcidsIBA
09/2014
1Potassium Sparing DiureticsIBA
02/2006
1GlucocorticoidsIBA
02/2006
1Hydrocortisone (Cortisol)FDA LinkGeneric
02/2006
1Mixed Function Oxygenases (Monooxygenases)IBA
02/2006
1MineralocorticoidsIBA
02/2006
1SteroidsIBA
02/2006

Therapy/Procedure

3Therapeutics
06/2020 - 02/2006
2Enzyme Replacement Therapy
06/2022 - 06/2020